The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.

@article{Olchanski2015ThePE,
  title={The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.},
  author={Natalia Olchanski and Yue Zhong and Joshua Cohen and Cayla J. Saret and Mohan Bala and Peter J Neumann},
  journal={Expert review of pharmacoeconomics & outcomes research},
  year={2015},
  volume={15 6},
  pages={
          931-40
        }
}
Published literature lacks consensus, and most guidelines lack definitive recommendations as to whether cost-effectiveness analyses (CEAs) should include all "future" costs or distinguish between related and unrelated medical costs. This systematic review of oncology CEAs evaluated cost methods used and the impact on the cost-effectiveness of incorporating different cost categories, including costs due to study intervention, related medical costs of the treated condition, and unrelated medical… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Topics from this paper.

Similar Papers

Loading similar papers…